Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're taking Mounjaro for weight management, staying well hydrated matters more than many people realise — and there's a lot of confusion online about why. To be direct: Mounjaro (tirzepatide) is a pre-filled injectable pen; it is never mixed with water before use. Good hydration supports how your body tolerates the medicine and helps manage its most common side effects. As a prescription-only medicine, Mounjaro requires a clinical assessment before a prescriber decides whether it's suitable for you — but if you're already prescribed it, the guidance below is grounded in verified UK clinical sources.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Search for 'Mounjaro and water' and a significant chunk of results concern reconstituting tirzepatide powder with bacteriostatic water. That process applies to compounded or research-grade tirzepatide, not to licensed Mounjaro KwikPens. Each Mounjaro pen comes from the manufacturer pre-filled, pre-dosed and ready to use. There is nothing to mix, no diluent to add, no calculation to make. If you have been told otherwise, or if something you received does not look like the standard pen, stop and contact your prescriber.
Pages covering tirzepatide and BAC water are relevant only in specific research or compounding contexts, and if you have come across instructions on how to mix tirzepatide with water, those apply to compounded preparations rather than anything you would receive from a GPhC-registered UK pharmacy. The pre-filled pen is the only licensed UK presentation of tirzepatide for weight management.
Understanding this distinction matters for safety. Compounded tirzepatide preparations are not regulated in the same way as the licensed product, and the MHRA has warned publicly about illegally traded and fake weight-loss pens seized across the UK. If you are unsure whether what you have is genuine licensed Mounjaro, the MHRA Yellow Card scheme allows you to report suspect products.
Mounjaro slows gastric emptying and reduces appetite, both useful for weight loss, but both capable of affecting how much you drink day to day. Some people find they forget to drink because they feel full, or because nausea makes everything feel unappealing. The result can be mild dehydration that makes GI side effects worse and energy levels lower.
The NHS notes that severe vomiting or diarrhoea from GLP-1 medicines can lead to dehydration serious enough to affect kidney function. Keeping fluid intake consistent (not heroic, just steady) is one of the more practical things you can do to manage the early weeks of treatment. Plain water is the obvious choice; the question of fruit juice and other drinks on Mounjaro is worth understanding separately, since some high-sugar options can work against the medicine's appetite effects.
A quick habit that takes less than a minute: before your weekly injection day, count how many times you filled and drank from your usual glass or bottle the previous day. If it was fewer than five or six, your fluid intake is probably on the low side. You don't need an app or a tracker, just the count.
For more detail on daily targets and what counts towards your intake, the full guide to Mounjaro water intake covers the practicalities without overclaiming on precise figures.
Mild nausea and a reduced appetite for drinking are common, especially in the first few weeks or after a dose increase. They are different from the dehydration that warrants medical attention. Signs that your body is struggling include very dark urine, dizziness on standing, an inability to keep fluids down for more than a few hours, and (rarer but serious) severe stomach pain that extends towards the back. That last symptom should prompt urgent medical review: in January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, with persistent stomach pain as the key warning sign.
Less dramatic but still worth noting: constipation (another common Mounjaro side effect) is made significantly worse by low fluid intake. Increasing water before reaching for laxatives is often the more useful first step, and one most prescribers suggest early on.
If side effects are making it hard to stay hydrated, your prescriber or clinical team should know. Dose timing, pace of titration and practical dietary changes are all adjustable, but only if the conversation happens. At nume, our clinical team is reachable seven days a week for exactly this kind of aftercare question.
Hydration sits alongside reduced-calorie eating and increased physical activity as part of the lifestyle framework that licensed weight-management treatment is designed to support. The tirzepatide overview covers what the medicine is and how it works at a mechanism level. The NICE appraisal of tirzepatide, TA1026, sets out the clinical evidence base and eligibility criteria for NHS use, useful reading if you want to understand the full picture.
Mounjaro is a prescription-only medicine. A prescriber assesses your full health history before treatment begins, and that assessment shapes the advice most relevant to you personally, including anything about hydration, diet and managing side effects. General guidance like the above is a useful starting point; it is not a substitute for your own clinical review. If you haven't yet had that conversation, checking your eligibility with our prescribers is the place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.